Advanced Drones to Enhance Training Against Multinational Forces at Joint Multinational Readiness Center WICHITA, Kan., Oct. 30, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is proud to announce the sale of three eBee VISION drones to the U.S. Army’s 1st Battalion, 4th Infantry Regiment (1-4 IN), stationed at the Joint Multinational Readiness Center (JMRC) in Hohenfels, Germ ...

Core Points - Australian Oilseeds Holdings Limited has regained compliance with Nasdaq's minimum bid price requirement and will transfer its listing to The Nasdaq Capital Market effective October 31, 2025 [1][2][3] - The transfer is not expected to impact trading of the Company's securities, which will continue to trade under the symbols "COOT" for Class A ordinary shares and "COOTW" for warrants [2] - The Nasdaq Capital Market has similar operational standards to the Nasdaq Global Market, requiring companies to meet specific financial and corporate governance criteria for continued listing [2] Company Overview - Australian Oilseeds Holdings Limited is focused on the manufacture and sale of sustainable oilseeds, including non-GMO and organic food-grade oils, targeting the growing oilseeds market [3] - The Company operates the largest cold pressing oil plant in Australia, emphasizing the production of GMO-free conventional and organic oilseeds [3] - The Company aims to eliminate chemicals from its production processes, thereby supplying healthier food ingredients and vegetable oils to customers globally [3]

MATTOON, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial results for the quarter ended September 30, 2025. Highlights Quarterly net income of $22.5 million, or $0.94 diluted EPSAdjusted quarterly net income* of $23.3 million, or $0.97 diluted EPSNet interest margin tax equivalent* expands to 3.80%, quarterly increase of 8 basis points, helping drive the sixth consecutive quarter of growth in net interest incomeTotal loans of $5. ...

Core Insights - Kojamo plc reported an improvement in occupancy rates, with total revenue and net rental income showing increases during the review period [1][6][12] Financial Performance - Total revenue for Q3 2025 was EUR 113.6 million, a 0.4% increase from EUR 113.2 million in Q3 2024 [5][6] - Net rental income for Q3 2025 was EUR 86.0 million, up 0.3% from EUR 85.7 million in Q3 2024, representing a margin of 75.7% [5][6] - Profit before taxes for Q3 2025 was EUR 32.8 million, down 35.2% from EUR 50.6 million in Q3 2024, influenced by a net loss of EUR 16.4 million from property valuations [5][6] - Funds From Operations (FFO) decreased by 3.3% to EUR 44.1 million in Q3 2025 compared to EUR 45.6 million in Q3 2024 [5][6] Investment and Property Management - Kojamo owned 39,001 rental apartments at the end of the review period, a decrease from 40,973 apartments the previous year [4] - Gross investments in Q3 2025 totaled EUR 13.6 million, representing 12.0% of total revenue, compared to EUR 2.2 million in Q3 2024 [5][6] - The fair value of investment properties was EUR 7.6 billion at the end of the review period, including EUR 41.8 million in properties held for sale [6] Occupancy and Market Conditions - The financial occupancy rate improved to 94.4% during the review period, with a further increase to 96.1% in Q3 2025 [6][13] - The rental market is balancing, with oversupply in the capital region but normalizing conditions in cities like Tampere and Turku [14] Strategic Developments - The company completed the sale of 44 residential properties, comprising 1,944 apartments, using EUR 200 million of the proceeds to repay loans [15] - A share buyback program was initiated, with plans to use up to EUR 75 million for buybacks [15] - A strategy review is underway to update the existing strategy, with further information expected during the financial statements publication [17] Outlook - Kojamo estimates a total revenue increase of 0-2% year-on-year for 2025, with FFO projected to be between EUR 135-141 million, excluding non-recurring costs [8][10]

MADRID, Spain and CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events: BIO-EUROPE, November 3-5Location: Viena Congress and Convention Center, Vienna, Austria LSX Investival Showcase Europe 2025, November 17Location: Old Billingsgate, London, United Kingdom Jefferies Global Healthcare Conferenc ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go, today announced its partnership with Priority Pass, the world’s leading airport experiences program, is going global. What first launched in North America last year is now being expanded to key international airports across the Middle East and Europe, giving travelers more ways to take care of themselves mid-journey. Through the expanded collaborat ...

Gross proceeds from sales of shares amounting to $4.5 million and exercise of warrants providing a further $2.7 millionTotal gross inflow of cash of $14.7 million since the end of the second quarter 2025Evaxion now has cash on hand to fund its operations and R&D programs into the second half of 2027The exercises have reduced the number of outstanding warrants to purchase Evaxion American Depositary Shares (ADSs) by 1.0 million COPENHAGEN, Denmark, October 30, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a ...

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ObesityWeek® 2025, taking place November 4-7, 2025 in Atlanta, Georgia. The presentations will highlight preclinical data for BMF-650, Biomea’s next-generation oral small molecule glucagon-like peptide-1 (“GLP-1”) receptor agonist (“RA”), and combination data for icovamenib, the company’s fir ...

Authorization Positions Company to Generate Non-Dilutive, Tax-Free Capital to Support Growth, Innovation, and Sustainable ExpansionBELVIDERE, NJ, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that the New Jersey Economic Development Authority (NJEDA) has preliminarily approved the Company’s application ...

Agreement Strengthens Plug’s Global Portfolio of Utility-Scale Hydrogen and Sustainable Fuel DevelopmentsSLINGERLANDS, N.Y., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced the execution of a binding supply agreement with Allied Biofuels FE LLC (ABF) for up to 2 gigawatts (GW) of Plug’s GenEco PEM electrolyzer systems. The agreement supports ABF’s development of sustainable aviation fuel (SAF), el ...